切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2013, Vol. 02 ›› Issue (04) : 239 -243. doi: 10.3877/cma.j.issn.2095-3259.2013.04.004

所属专题: 文献

专家论坛

子痫前期不良妊娠结局的预测
常小洁1, 王子莲1,()   
  1. 1. 510080 广州,中山大学附属第一医院妇产科
  • 收稿日期:2013-08-16 出版日期:2013-11-18
  • 通信作者: 王子莲

Prediction of preeclampsia adverse outcomes

Xiao-jie CHANG1, Zi-lian WANG1()   

  • Received:2013-08-16 Published:2013-11-18
  • Corresponding author: Zi-lian WANG
引用本文:

常小洁, 王子莲. 子痫前期不良妊娠结局的预测[J]. 中华产科急救电子杂志, 2013, 02(04): 239-243.

Xiao-jie CHANG, Zi-lian WANG. Prediction of preeclampsia adverse outcomes[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2013, 02(04): 239-243.

[1]
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol, 2009, 33(3):130-137.
[2]
Ganzevoort W, Rep A, de Vries JI, et al. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol, 2006, 195(2):495-503.
[3]
Stamilio DM, Sehdev HM, Morgan MA, et al. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?. Am J Obstet Gynecol, 2000, 182(3):589-594.
[4]
Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation, 2012, 125(7):911-919.
[5]
Magee LA, Helewa M, Moutquin JM, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can, 2008, 30(3 Suppl):S1-S48.
[6]
Martin JJ, May WL, Magann EF, et al. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol, 1999, 180(6 Pt 1):1407-1414.
[7]
Witlin AG, Saade GR, Mattar F, et al. Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol, 1999, 180(6 Pt 1):1322-1329.
[8]
Thangaratinam S, Gallos ID, Meah N, et al. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand, 2011, 90(6):564-573.
[9]
Chan P, Brown M, Simpson JM, et al. Proteinuria in pre-eclampsia: how much matters?. BJOG, 2005, 12(3):280-285.
[10]
von Dadelszen P, Magee LA, Devarakonda RM, et al. The prediction of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can, 2004, 26(10):871-879.
[11]
伍绍文,吴连方,王琪,等. 早发型重度子痫前期孕妇期待治疗中不良妊娠结局的危险因素分析. 中华妇产科杂志,2010, 45(3):165-169.
[12]
Morris RK, Riley RD, Doug M, et al. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ, 2012, 345:e4342.
[13]
Haas DM, Sabi F, Mcnamara M, et al. Comparing ambulatory spot urine protein/creatinine ratios and 24-h urine protein measurements in normal pregnancies. J Matern Fetal Neonatal Med, 2003, 14(4):233-236.
[14]
Menzies J, Magee LA, Macnab YC, et al. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy, 2007, 26(4):447-462.
[15]
Schiff E, Friedman SA, Kao L, et al. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol, 1996, 175(5):1313-1316.
[16]
Thangaratinam S, Coomarasamy A, O′Mahony F, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med, 2009, 7:10.
[17]
Repke JT. What is new in preeclampsia?:best articles from the past year. Obstet Gynecol, 2013, 121(3):682-683.
[18]
Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta, 2008, 29 Suppl A:S67-S72.
[19]
Thangaratinam S, Ismail KM, Sharp S, et al. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG, 2006, 113(4):369-378.
[20]
Hawkins TL, Roberts JM, Mangos GJ, et al. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG, 2012, 119(4):484-492.
[21]
Koopmans CM, van Pampus MG, Groen H, et al. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol, 2009, 146(1):8-14.
[22]
高慧,王双连. 妊娠高血压综合征患者血清尿酸变化对围产儿预后的影响. 中国妇幼保健,2006, 21(7):893-896.
[23]
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004, 350(7):672-683.
[24]
Rana S, Schnettler WT, Powe C, et al. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy, 2013, 32(2): 189-201.
[25]
Rana S, Cerdeira AS, Wenger J, et al. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One, 2012, 7(10):e48259.
[26]
Sibiude J, Guibourdenche J, Dionne MD, et al. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One, 2012, 7(11):e50208.
[27]
Thangaratinam S, Koopmans CM, Iyengar S, et al. Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstet Gynecol Scand, 2011, 90(6):574-585.
[28]
侯卫萍,刘继晓. 96例子痫前期患者的凝血指标及妊娠结局.中国妇幼保健,2010, 25(34):4982-4984.
[29]
宋伟夫,徐红梅,李娜,等. 孕妇血清游离雌三醇水平联合NST试验对重度子痫前期患者围产儿结局的评估. 吉林大学学报(医学版), 2012, 38(1):159-161.
[30]
葛妍圻. 子痫前期胎儿脐动脉及大脑中动脉血流检测与围生儿预后分析. 齐齐哈尔医学院学报,2011, 32(16):2591-2592.
[31]
Kafkasli A, Turkcuoglu I, Turhan U. Maternal, fetal and perinatal characteristics of preeclampsia cases with and without abnormalities in uterine artery Doppler indexes. J Matern Fetal Neonatal Med, 2013, 26(9): 936-940.
[32]
张满云,肖小敏. 孕中期子宫动脉血流多普勒检查预测妊娠期高血压疾病初探. 实用妇产科杂志,2011, 27(4):300-303.
[33]
Shahinaj R, Manoku N, Kroi E, et al. The value of the middle cerebral to umbilical artery Doppler ratio in the prediction of neonatal outcome in patient with preeclampsia and gestational hypertension. J Prenat Med, 2010, 4(2):17-21.
[34]
Eser A, Zulfikaroglu E, Eserdag S, et al. Predictive value of middle cerebral artery to uterine artery pulsatility index ratio in preeclampsia. Arch Gynecol Obstet, 2011, 284(2):307-311.
[35]
Simanaviciute D, Gudmundsson S. Fetal middle cerebral to uterine artery pulsatility index ratios in normal and pre-eclamptic pregnancies. Ultrasound Obstet Gynecol, 2006, 28(6):794-801.
No related articles found!
阅读次数
全文


摘要